Author

J. A. Van Deventer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Organism:yeast· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1

Frequent Co-Authors

A. Harthorn· 1 shared A. Rezhdo· 1 shared B. J. Hackel· 1 shared C. T. Lessard· 1 shared F. Ma· 1 shared M. Huang· 1 shared M. Islam· 1 shared M. Rueda-Garcia· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Harthorn

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Systematic evaluation of protein-small molecule hybrids on the yeast surface

M. Huang, M. Rueda-Garcia, A. Harthorn, B. J. Hackel, J. A. Van Deventer

This study evaluates protein-small molecule hybrids on yeast surfaces, showing tolerance to chemical diversity and unexpected functional outcomes.

bioRxiv · May 12, 2023Bioengineering

Strategies for enriching and characterizing proteins with inhibitory properties on the yeast surface

A. Rezhdo, C. T. Lessard, M. Islam, J. A. Van Deventer

This paper develops strategies to discover and characterize inhibitory antibodies using yeast display, showing that IC50 values can be measured directly on the yeast surface.

bioRxiv · Apr 20, 2022Bioengineering

Intracellular Delivery of Antibodies for Selective Cell Signaling Interference

R. L. Hershman, Y. Li, F. Ma, Q. Xu, J. A. Van Deventer

This paper demonstrates the use of cationic lipid nanoparticles to deliver engineered antibodies into cells, enabling selective disruption of intracellular signaling via pYSTAT3.

bioRxiv · Oct 5, 2021Bioengineering